To confirm the effects of miR-146a on EGFR, we transfected the NSCLC cells with the miR-146a inhibitor and found that inhibition of miR-146a increased the levels of p-EGFR, EGFR and downstream signaling (Figure 10). Here, EGFR is linked to non-small cell lung carcinoma.